KEI Comments on NIH Exclusive License to Neurala for Central Nervous System Disorders

On June 2, 2025, Knowledge Ecology International (KEI) offered comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: c-Abl Tyrosine Kinase Inhibitory Compound Embodiments and Methods of Making and Using the Same”… Continue Reading

WHA 78 – Constituency statement of Knowledge Ecology International, Health Action International, Oxfam, World Blind, Union and World Council of Churches – WHO Pandemic Accord

On Monday, 19 January 2025,Knowledge Ecology International (KEI) delivered this constituency statement on behalf of KEI, Health Action International, Oxfam, World Blind Union, and World Council of Churches on the following topic: Intergovernmental Negotiating Body to draft and negotiate a… Continue Reading

KEI Comments on NIH Exclusive License to Sangam Lifesciences for Drug Delivery Platform

On May 7, 2025, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Size-Dependent Brain and Lymphatic Distribution of Macromolecular Drug Delivery Platform” (90 FR 16878) to… Continue Reading